• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有心脏危险因素的骨科患者静脉血栓栓塞预防的依从性

Venous Thromboembolism Prophylaxis Compliance in Orthopedic Patients With Cardiac Risk Factors.

作者信息

Asif Usama, Ghani Usman, Zia Sheikh Muhammad Rehman, Majeed Farhan, Usman Muhammad, Amjad Aqsa, Khan Humna, Qammar Bilal

机构信息

Internal Medicine, Aziz Bhatti Shaheed Teaching Hospital, Gujrat, PAK.

Cardiology, Army Cardiac Hospital, Lahore, PAK.

出版信息

Cureus. 2025 Feb 27;17(2):e79772. doi: 10.7759/cureus.79772. eCollection 2025 Feb.

DOI:10.7759/cureus.79772
PMID:40161189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11954410/
Abstract

Introduction Venous thromboembolism (VTE) is a critical condition that includes deep vein thrombosis (DVT) and pulmonary embolism (PE), both of which can lead to severe complications, including death, if not adequately managed. Objective This study aimed to evaluate adherence to prophylactic measures and identify factors influencing compliance. Methodology This study was done in Shalamar Hospital, Lahore, from October 2023 to October 2024. Baseline assessments were conducted to gather demographic and clinical data, including age, gender, body mass index (BMI), comorbidities, and cardiac risk factors such as atrial fibrillation or coronary artery disease. Details of the surgical procedures, including type, duration, and anesthesia used, were also recorded. Compliance with VTE prophylaxis was monitored through patient interviews, direct observation, and medical record reviews. Pharmacological prophylaxis compliance involved evaluating the administration of anticoagulants regarding dosage, timing, and frequency. Mechanical prophylaxis adherence was assessed by monitoring the use of compression stockings and pneumatic devices. Compliance was measured as the percentage of patients who adhered to the prescribed prophylaxis protocols. Primary outcomes included the incidence of VTE events, such as DVT or PE, within 30 days post-surgery. Follow-ups were conducted through in-person visits or telephonic interactions to monitor compliance and postoperative outcomes. Data were analyzed using IBM SPSS Statistics for Windows, Version 26.0 (Released 2019; IBM Corp., Armonk, New York, United States). Continuous variables, such as age and BMI, were summarized using means and standard deviations, while categorical variables, like compliance rates, were expressed as frequencies and percentages. Subgroup analyses were conducted to identify variations in compliance rates based on demographic and clinical factors using t-tests. Results The study included 90 patients, with a mean age of 58.9±8.4 years and a nearly equal gender distribution (54% male and 46% female). The mean BMI of the participants was 28.5±3.2 kg/m². Hypertension was the most common cardiac risk factor, affecting 67% (n=60) of patients, followed by atrial fibrillation (22%; n=20) and heart failure (11%; n=10). Among the surgeries, 65% (n=58) were elective, while 35% (n=32) were emergency procedures. VTE incidence was 6.7% (n=6), with 4.4% (n=4) developing DVT and 2.2% (n=2) experiencing PE. Bleeding complications occurred in 8.9% (n=8) of patients, with 6.7% (n=6) experiencing minor bleeding and 2.2% (n=2) reporting major bleeding. Patients undergoing elective surgeries exhibited higher pharmacological compliance at 78% (n=45) and mechanical compliance at 88% (n=51), resulting in an overall compliance rate of 84% (n=49). In contrast, patients undergoing emergency surgeries had lower compliance rates, with 63% (n=20) for pharmacological prophylaxis and 69% (n=22) for mechanical prophylaxis, leading to an overall compliance rate of 63% (n=20). Conclusion It is concluded that compliance with VTE prophylaxis plays a pivotal role in reducing the risk of thromboembolic events in orthopedic patients with cardiac risk factors.

摘要

引言

静脉血栓栓塞症(VTE)是一种严重疾病,包括深静脉血栓形成(DVT)和肺栓塞(PE),如果管理不当,两者都可能导致严重并发症,包括死亡。

目的

本研究旨在评估预防性措施的依从性,并确定影响依从性的因素。

方法

本研究于2023年10月至2024年10月在拉合尔的沙勒马尔医院进行。进行基线评估以收集人口统计学和临床数据,包括年龄、性别、体重指数(BMI)、合并症以及心脏危险因素,如房颤或冠状动脉疾病。还记录了手术程序的详细信息,包括类型、持续时间和使用的麻醉方法。通过患者访谈、直接观察和病历审查来监测VTE预防措施的依从性。药物预防依从性涉及评估抗凝剂的给药剂量、时间和频率。通过监测压力袜和气垫装置的使用情况来评估机械预防的依从性。依从性以遵守规定预防方案的患者百分比来衡量。主要结局包括术后30天内VTE事件(如DVT或PE)的发生率。通过面对面访视或电话沟通进行随访,以监测依从性和术后结局。使用IBM SPSS Statistics for Windows 26.0版(2019年发布;IBM公司,美国纽约州阿蒙克)进行数据分析。连续变量,如年龄和BMI,用均值和标准差进行汇总,而分类变量,如依从率,用频率和百分比表示。使用t检验进行亚组分析,以确定基于人口统计学和临床因素的依从率差异。

结果

该研究纳入了90名患者,平均年龄为58.9±8.4岁,性别分布接近相等(男性54%,女性46%)。参与者的平均BMI为28.5±3.2kg/m²。高血压是最常见的心脏危险因素,影响67%(n = 60)的患者,其次是房颤(22%;n = 20)和心力衰竭(11%;n = 10)。在手术中,65%(n = 58)为择期手术,35%(n = 32)为急诊手术。VTE发生率为6.7%(n = 6),其中4.4%(n = 4)发生DVT,2.2%(n = 2)发生PE。8.9%(n = 8)的患者发生出血并发症,其中6.7%(n = 6)为轻微出血,2.2%(n = 2)为大出血。接受择期手术的患者药物依从性较高,为78%(n = 45),机械依从性为88%(n = 51),总体依从率为84%(n = 49)。相比之下,接受急诊手术的患者依从率较低,药物预防依从率为63%(n = 20),机械预防依从率为69%(n = 22),总体依从率为63%(n = 20)。

结论

得出结论,对于有心脏危险因素的骨科患者,遵守VTE预防措施在降低血栓栓塞事件风险方面起着关键作用。

相似文献

1
Venous Thromboembolism Prophylaxis Compliance in Orthopedic Patients With Cardiac Risk Factors.具有心脏危险因素的骨科患者静脉血栓栓塞预防的依从性
Cureus. 2025 Feb 27;17(2):e79772. doi: 10.7759/cureus.79772. eCollection 2025 Feb.
2
Association Between Venous Thromboembolism Prophylaxis and the Incidence of Thromboembolism Following Orthopedic Procedures: A Cross-Sectional Study.骨科手术后静脉血栓栓塞预防措施与血栓栓塞发生率之间的关联:一项横断面研究。
Cureus. 2024 Jan 21;16(1):e52652. doi: 10.7759/cureus.52652. eCollection 2024 Jan.
3
Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.药物干预预防接受减重手术人群的静脉血栓栓塞症。
Cochrane Database Syst Rev. 2022 Nov 22;11(11):CD013683. doi: 10.1002/14651858.CD013683.pub2.
4
Neuromuscular electrical stimulation for the prevention of venous thromboembolism.用于预防静脉血栓栓塞的神经肌肉电刺激
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011764. doi: 10.1002/14651858.CD011764.pub2.
5
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism.联合间歇性气动腿部压迫和药物预防预防静脉血栓栓塞症。
Cochrane Database Syst Rev. 2022 Jan 28;1(1):CD005258. doi: 10.1002/14651858.CD005258.pub4.
6
Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.成人膝关节镜检查中预防静脉血栓栓塞症的干预措施。
Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD005259. doi: 10.1002/14651858.CD005259.pub5.
7
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism.联合间歇性气动腿部压迫与药物预防以预防静脉血栓栓塞
Cochrane Database Syst Rev. 2016 Sep 7;9(9):CD005258. doi: 10.1002/14651858.CD005258.pub3.
8
Standard- versus extended-duration anticoagulation for primary venous thromboembolism prophylaxis in acutely ill medical patients.急性病内科患者原发性静脉血栓栓塞症预防中标准疗程与延长疗程抗凝治疗的比较
Cochrane Database Syst Rev. 2024 Dec 4;12(12):CD014541. doi: 10.1002/14651858.CD014541.pub2.
9
Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity.下肢大截肢患者静脉血栓栓塞的一级预防。
Cochrane Database Syst Rev. 2020 Jul 21;7(7):CD010525. doi: 10.1002/14651858.CD010525.pub3.
10
Prophylaxis against venous thromboembolism in orthopedic surgery.骨科手术中静脉血栓栓塞的预防
Chin J Traumatol. 2006 Aug;9(4):249-56.

引用本文的文献

1
Improving Patient Care and Clinical Services: Compliance With the National Institute for Health and Care Excellence (NICE) Guidelines for Venous Thromboembolism Prophylaxis After Hip and Knee Arthroplasty.改善患者护理与临床服务:遵循英国国家卫生与临床优化研究所(NICE)关于髋膝关节置换术后静脉血栓栓塞预防的指南
Cureus. 2025 Jun 20;17(6):e86448. doi: 10.7759/cureus.86448. eCollection 2025 Jun.

本文引用的文献

1
Racial and Socioeconomic Determinants of Cardiovascular Health: A Comprehensive Review.心血管健康的种族和社会经济决定因素:一项综合综述。
Cureus. 2024 May 2;16(5):e59497. doi: 10.7759/cureus.59497. eCollection 2024 May.
2
Venous Thromboembolism Prophylaxis in Major Orthopedic Surgeries and Factor XIa Inhibitors.骨科大手术与因子 XIa 抑制剂预防静脉血栓栓塞症
Med Sci (Basel). 2023 Aug 11;11(3):49. doi: 10.3390/medsci11030049.
3
Pharmacology and Clinical Development of Factor XI Inhibitors.因子 XI 抑制剂的药理学和临床开发。
Circulation. 2023 Mar 14;147(11):897-913. doi: 10.1161/CIRCULATIONAHA.122.062353. Epub 2023 Mar 13.
4
Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial.髋关节或膝关节置换术后阿司匹林与依诺肝素对有症状静脉血栓栓塞症的影响:CRISTAL 随机试验。
JAMA. 2022 Aug 23;328(8):719-727. doi: 10.1001/jama.2022.13416.
5
Role of Direct Oral Anticoagulants for Post-operative Venous Thromboembolism Prophylaxis.直接口服抗凝剂在术后静脉血栓栓塞预防中的作用。
Eur Cardiol. 2022 May 13;17:e11. doi: 10.15420/ecr.2021.55. eCollection 2022 Feb.
6
Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation.肥胖患者使用直接口服抗凝剂治疗和预防静脉血栓栓塞症:ISTH SSC 抗凝控制小组委员会的最新沟通。
J Thromb Haemost. 2021 Aug;19(8):1874-1882. doi: 10.1111/jth.15358. Epub 2021 Jul 14.
7
Treatment of superficial vein thrombosis with intermediate dose of tinzaparin: A real word cohort study - The SeVEN EXTension study.中剂量亭扎肝素治疗浅静脉血栓形成:真实世界队列研究——SeVEN EXTension 研究。
Phlebology. 2021 Jul;36(6):423-431. doi: 10.1177/0268355520947300. Epub 2021 Jan 6.
8
Comparison of two escalated enoxaparin dosing regimens for venous thromboembolism prophylaxis in obese hospitalized patients.肥胖住院患者静脉血栓栓塞症预防中两种强化依诺肝素给药方案的比较。
J Thromb Thrombolysis. 2021 Aug;52(2):577-583. doi: 10.1007/s11239-020-02360-9. Epub 2021 Jan 5.
9
Factor XI(a) inhibitors for thrombosis: an updated patent review (2016-present).因子 XI(a)抑制剂治疗血栓:更新的专利审查(2016 年至今)。
Expert Opin Ther Pat. 2020 Jan;30(1):39-55. doi: 10.1080/13543776.2020.1705783. Epub 2019 Dec 19.
10
Intermittent Pneumatic Compression for the Prevention of Venous Thromboembolism after Total Hip Arthroplasty.间歇性充气加压预防全髋关节置换术后静脉血栓栓塞
Clin Orthop Surg. 2017 Mar;9(1):37-42. doi: 10.4055/cios.2017.9.1.37. Epub 2017 Feb 13.